Paper Details

  1. Home
  2. Paper Details

Perampanel add-on for drug-resistant focal epilepsy.

Author: BresnahanRebecca, HillRuaraidh A, WangJin

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Epilepsy affects many people, and around 30% don't respond well to standard medications. Perampanel is a newer drug that's being studied as an additional treatment for those with epilepsy that doesn't improve with other medications.
Paper Details　
Original Abstract of the Article :
Epilepsy is one of the most common neurological disorders. Approximately 30% of people with epilepsy are considered to be drug-resistant, and usually need treatment with a combination of other antiepileptic drugs. Perampanel is a newer antiepileptic drug that has been investigated as add-on therapy ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103545/

データ提供：米国国立医学図書館（NLM）

A New Hope for Drug-Resistant Epilepsy

Epilepsy, a neurological disorder characterized by seizures, can be a challenging condition to manage, especially when traditional antiepileptic drugs fail to control seizures. This study focuses on the potential of perampanel, a newer antiepileptic drug, as an add-on therapy for drug-resistant focal epilepsy. The study examined the use of perampanel in patients who had not responded to other medications, exploring its effectiveness in reducing seizure frequency and improving overall quality of life.

Perampanel: A Potential Lifeline for Drug-Resistant Epilepsy

This study provides a glimmer of hope for patients with drug-resistant epilepsy. Perampanel, a newer antiepileptic drug, has shown promising results as an add-on therapy for those who have not responded to conventional treatments. The study suggests that perampanel could potentially offer a new pathway to seizure control and improved quality of life for patients battling this challenging condition.

A New Oasis for Epilepsy Patients

This research, like a fresh spring in a barren desert, brings hope to individuals struggling with drug-resistant epilepsy. Perampanel, a newer antiepileptic drug, offers a potential lifeline for patients who have exhausted conventional treatment options. This study provides a compelling starting point for exploring the potential of perampanel as a viable treatment for drug-resistant epilepsy.

Dr.Camel's Conclusion

Like a camel caravan seeking a fertile oasis in the desert, this study offers a potential solution for individuals struggling with drug-resistant epilepsy. Perampanel, a newer antiepileptic drug, may be a beacon of hope for patients seeking a path toward better seizure control and a more fulfilling life. This research provides a roadmap for future exploration and underscores the importance of continued research in this field.

Date :
  1. Date Completed 2023-04-18
  2. Date Revised 2023-07-01
Further Info :

Pubmed ID

37059702

DOI: Digital Object Identifier

PMC10103545

Related Literature

Article Analysis
・Effective treatment of epilepsy
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.